VX1 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Vertex Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 227.65 EUR 1.16% Market Closed

Market Cap: €89.4B

V	Vertex Pharmaceuticals Inc XETRA:VX1	US
T	Thomson Reuters Corp NYSE:TRI	CA
S	Sealed Air Corp XBER:SDA	US
S	Stericycle Inc LSE:0L9O	US
M	Micron Technology Inc XETRA:MTE	US
D	Dover Corp LSE:0ICP	US
	Southwest Airlines Co NYSE:LUV	US

Profitability Summary

Vertex Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

86%

Strong 3Y Average Gross Margin

87%

Declining Gross Margin

88% > 86%

Exceptional Operating Margin

39%

Strong 3Y Average Operating Margin

41%

Declining Operating Margin

49% > 39%

Exceptional Net Margin

36%

Sustainable 3Y Average Net Margin

21%

Net Margin is Increasing

35% > 36%

Exceptional Free Cash Flow Margin

26%

Strong 3Y Average Free Cash Flow Margin

18%

Declining Free Cash Flow Margin

42% > 26%

Positive ROE

24%

Positive 3Y Average ROE

Positive 3Y Average ROIC

11%

Declining ROIC

50% > 25%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.